The Pro-Oncogenic Protein IF₁ Promotes Proliferation of Anoxic Cancer Cells during Re-Oxygenation

Area of Science:

• Mitochondrial bioenergetics
• Cancer cell metabolism

Background:

• Cancer cells often overexpress IF1, an inhibitor of ATP synthase, particularly under ischemic conditions.
• The precise roles and molecular mechanisms of IF1 in cancer cell survival and proliferation are not fully understood.

Purpose of the Study:

• To investigate the role of IF1 in promoting survival and proliferation of osteosarcoma and colon carcinoma cells under simulated ischemia-reperfusion conditions.
• To elucidate the mechanisms by which IF1 influences mitochondrial dynamics and cellular energy homeostasis.

Main Methods:

• Utilized IF1-silenced and parental cancer cell lines (osteosarcoma, colon carcinoma).
• Induced mitochondrial membrane potential (ΔμH+) collapse using FCCP uncoupler to mimic ischemia.
• Assessed mitochondrial mass, mitophagy, mitochondrial biogenesis, and cellular proliferation post-uncoupler washout (re-oxygenation).

Main Results:

• IF1-expressing cells, unlike silenced cells, increased mitophagy and mitochondrial biogenesis upon ΔμH+ collapse and energy charge preservation.
• IF1 presence conferred a proliferative advantage to cells highly dependent on oxidative phosphorylation after re-oxygenation.
• IF1 facilitates energy preservation and mitochondrial renewal in anoxic cancer cells.

Conclusions:

• IF1 promotes cancer cell survival and proliferation under conditions mimicking solid tumor microenvironments.
• IF1's role in energy preservation and mitochondrial renewal supports tumor growth.
• Targeting IF1 presents a potential therapeutic strategy for cancers reliant on oxidative phosphorylation.